Morgan Stanley’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9
Closed -$4 8036
2024
Q1
$4 Sell
9
-9
-50% -$7 ﹤0.01% 7793
2023
Q4
$12 Buy
18
+9
+100% +$7 ﹤0.01% 7777
2023
Q3
$8 Buy
9
+2
+29% +$2 ﹤0.01% 7573
2023
Q2
$13 Sell
7
-1
-13% -$3 ﹤0.01% 7595
2023
Q1
$28 Sell
8
-1
-11% -$5 ﹤0.01% 7627
2022
Q4
$36 Buy
9
+1
+13% +$5 ﹤0.01% 7748
2022
Q3
$0 Sell
8
-4
-33% -$66 ﹤0.01% 7968
2022
Q2
$0 Sell
12
-39
-76% -$915 ﹤0.01% 8074
2022
Q1
$2K Sell
51
-420
-89% -$14.5K ﹤0.01% 7778
2021
Q4
$26K Sell
471
-2,541
-84% -$171K ﹤0.01% 7116
2021
Q3
$218K Sell
3,012
-2,972
-50% -$227K ﹤0.01% 5958
2021
Q2
$574K Buy
5,984
+4,772
+394% +$527K ﹤0.01% 5445
2021
Q1
$180K Buy
1,212
+67
+6% +$12.1K ﹤0.01% 5716
2020
Q4
$161K Buy
1,145
+561
+96% +$90.9K ﹤0.01% 5700
2020
Q3
$89K Sell
584
-168
-22% -$27.4K ﹤0.01% 5480
2020
Q2
$132K Buy
752
+275
+58% +$46K ﹤0.01% 5272
2020
Q1
$68K Buy
477
+87
+22% +$11.5K ﹤0.01% 5349
2019
Q4
$56K Buy
390
+15
+4% +$1.76K ﹤0.01% 5829
2019
Q3
$37K Buy
375
+364
+3,309% +$35.9K ﹤0.01% 5834
2019
Q2
$0 Buy
11
+1
+10% +$57 ﹤0.01% 6791
2019
Q1
$0 Sell
10
-2
-17% -$96 ﹤0.01% 6754
2018
Q4
$0 Sell
12
-2
-14% -$145 ﹤0.01% 6778
2018
Q3
$1K Hold
14
﹤0.01% 6664
2018
Q2
$1K Buy
14
+5
+56% +$436 ﹤0.01% 6619
2018
Q1
$1K Sell
9
-1
-10% -$149 ﹤0.01% 6563
2017
Q4
$7K Buy
10
+1
+11% +$386 ﹤0.01% 6291
2017
Q3
$3K Sell
9
-3
-25% -$819 ﹤0.01% 6372
2017
Q2
$3K Buy
12
+3
+33% +$806 ﹤0.01% 6425
2017
Q1
$3K Sell
9
-3
-25% -$1.39K ﹤0.01% 6431
2016
Q4
$7K Sell
12
-2
-14% -$2.11K ﹤0.01% 6234
2016
Q3
$16K Buy
14
+1
+8% +$1.08K ﹤0.01% 5984
2016
Q2
$14K Sell
13
-23
-64% -$28.9K ﹤0.01% 5967
2016
Q1
$47K Sell
36
-21
-37% -$29.9K ﹤0.01% 5632
2015
Q4
$139K Buy
57
+7
+14% +$10.7K ﹤0.01% 5247
2015
Q3
$55K Sell
50
-39
-44% -$45.2K ﹤0.01% 5692
2015
Q2
$90K Sell
89
-59
-40% -$63.6K ﹤0.01% 5638
2015
Q1
$150K Buy
148
+139
+1,544% +$459K ﹤0.01% 5344
2014
Q4
$30K Sell
9
-3
-25% -$9.2K ﹤0.01% 5958
2014
Q3
$35K Sell
12
-22
-65% -$72.8K ﹤0.01% 5835
2014
Q2
$129K Buy
34
+3
+10% +$11.3K ﹤0.01% 5379
2014
Q1
$167K Buy
31
+24
+343% +$126K ﹤0.01% 5200
2013
Q4
$21K Buy
+7
New +$21.6K ﹤0.01% 5849

Other funds holding NBSE